| Balance Sheet for Takeda Pharmaceutical Company Limited |
| (Amounts are in millions) |
| 3/2019 |
| 3/2018 |
| 3/2017 |
| Cash |
| $6,318.84 |
| $2,650.70 |
| $2,970.93 |
| Marketable Securities |
| $209.48 |
| $725.81 |
| $527.15 |
| Receivables |
| $6,742.07 |
| $3,859.13 |
| $4,136.44 |
| Inventory |
| $8,880.70 |
| $1,916.50 |
| $2,104.53 |
| Raw Materials |
| N/A |
| N/A |
| N/A |
| Work in Progress |
| N/A |
| N/A |
| N/A |
| Finished Goods |
| N/A |
| N/A |
| N/A |
| Notes Receivable |
| $0.00 |
| $0.00 |
| $0.00 |
| Other Current Assets |
| $5,304.83 |
| $557.14 |
| $1,985.09 |
|
|
 |
|
|
|
|
| Total Current Assets |
| $27,455.92 |
| $9,709.27 |
| $11,724.16 |
| |
|
|
|
|
|
|
| Property, Plant & Equipment |
| $17,594.57 |
| $10,722.58 |
| N/A |
| Accumulated Depreciation |
| $5,745.79 |
| $5,891.37 |
| N/A |
| Net Property, Plant & Equipment |
| $11,848.78 |
| $4,831.21 |
| $4,930.41 |
| Investment & Advances |
| $2,762.09 |
| $2,739.47 |
| $2,906.68 |
| Other non-current Assets |
| $0.00 |
| $0.00 |
| $0.00 |
| Deferred Charges |
| $800.92 |
| $584.82 |
| $1,106.40 |
| Intangibles |
| $81,195.94 |
| $18,391.61 |
| $19,423.48 |
| Deposits & other assets |
| $787.25 |
| $701.79 |
| $417.66 |
|
|
|
|
|
|
|
| TOTAL ASSETS |
| $124,850.90 |
| $36,958.17 |
| $40,508.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| Notes Payable |
| $0.00 |
| $0.00 |
| $0.00 |
| Accounts Payable |
| $2,946.55 |
| $2,162.33 |
| $2,237.79 |
| Current Portion of Long-term Debt |
| $8,864.51 |
| $0.16 |
| $5,068.76 |
| Current Portion of Capital Leases |
| $0.00 |
| $0.00 |
| $0.00 |
| Accrued Expenses |
| $0.00 |
| $0.00 |
| $0.00 |
| Income Taxes Payable |
| $1,075.37 |
| $609.25 |
| $656.43 |
| Other Current Liabilities |
| $9,711.95 |
| $3,865.84 |
| $4,741.66 |
|
|
|
|
|
|
|
| Total Current Liabilities |
| $22,598.38 |
| $6,637.58 |
| $12,704.65 |
| |
|
|
|
|
|
|
| Mortgages |
| $0.00 |
| $0.00 |
| $0.00 |
| Deferred Charges (taxes/income) |
| $7,803.55 |
| $816.53 |
| $1,535.97 |
| Convertible Debt |
| $0.00 |
| $0.00 |
| $0.00 |
| Long Term Debt |
| $42,894.05 |
| $8,870.80 |
| $5,578.72 |
| Non-Current Capital Leases |
| $0.00 |
| $0.00 |
| $0.00 |
| Other Long-Term Debt |
| $5,082.63 |
| $2,476.58 |
| $2,564.08 |
| Minority Interest (liabilities) |
| $0.00 |
| $0.00 |
| $0.00 |
|
|
|
|
|
|
|
| TOTAL LIABILITIES |
| $78,378.61 |
| $18,801.49 |
| $22,383.41 |
| |
|
|
|
|
|
|
| Preferred Stock |
| $0.00 |
| $0.00 |
| $0.00 |
| Common Stock, Net |
| $14,792.26 |
| $701.23 |
| $606.39 |
| Capital Surplus |
| $14,852.09 |
| $816.66 |
| $697.24 |
| Retained Earnings |
| $14,124.29 |
| $14,015.76 |
| $14,059.90 |
| Treasury Stock |
| $514.28 |
| $669.36 |
| $453.23 |
| Other Liabilities |
| $3,217.93 |
| $3,292.39 |
| $3,215.07 |
|
|
|
|
|
|
|
| SHAREHOLDERS' EQUITY |
| $46,472.29 |
| $18,156.68 |
| $18,125.38 |
|
|
|
|
|
|
|
| TOTAL LIABILITES &SHAREHOLDERS EQUITY |
| $124,850.90 |
| $36,958.17 |
| $40,508.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
